• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃塞俄比亚将动物研究转化为人体试验的挑战与机遇。

Challenges and opportunities of translating animal research into human trials in Ethiopia.

机构信息

Department of Biomedical Sciences, College of Veterinary Medicine and Animal Sciences, University of Gondar, P.O. Box: 196, Gondar, Ethiopia.

Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, P.O. Box 9086, Addis Ababa, Ethiopia.

出版信息

BMC Med Res Methodol. 2024 Sep 19;24(1):211. doi: 10.1186/s12874-024-02338-8.

DOI:10.1186/s12874-024-02338-8
PMID:39300349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11411908/
Abstract

BACKGROUND AND OBJECTIVES

Although the goal of translational research is to bring biomedical knowledge from the laboratory to clinical trial and therapeutic products for improving health, this goal has not been well achieved as often as desired because of many barriers documented in different countries. Therefore, the aim of this study was to investigate the challenges and opportunities of translating animal research into human trials in Ethiopia.

METHODS

A descriptive qualitative study, using in-depth interviews, was conducted in which preclinical and clinical trial researchers who have been involved in animal research or clinical trials as principal investigator were involved. Data were analyzed using inductive thematic process.

RESULTS

Six themes were emerged for challenges: lack of financial and human capacity, inadequate infrastructure, operational obstacles and poor research governance, lack of collaboration, lack of reproducibility of results and prolonged ethical and regulatory approval processes. Furthermore, three themes were synthesized for opportunities: growing infrastructure and resources, improved human capacity and better administrative processes and initiatives for collaboration.

CONCLUSION AND RECOMMENDATIONS

The study found that the identified characteristics/features are of high importance either to hurdle or enable the practice of translating animal research into human trials. The study suggests that there should be adequate infrastructure and finance, human capacity building, good research governance, improved ethical and regulatory approval process, multidisciplinary collaboration, and incentives and recognition for researchers to overcome the identified challenges and allow translating of animal research into human trials to proceed more efficiently.

摘要

背景和目的

尽管转化研究的目标是将生物医学知识从实验室转化为临床试验和治疗产品,以改善健康,但由于不同国家记录的许多障碍,这一目标并没有像预期的那样经常实现。因此,本研究旨在探讨在埃塞俄比亚将动物研究转化为人体试验的挑战和机遇。

方法

采用描述性定性研究方法,通过深入访谈,邀请参与动物研究或临床试验的主要研究者参与。使用归纳主题过程进行数据分析。

结果

出现了六个挑战主题:缺乏财务和人力资源、基础设施不足、运营障碍和较差的研究治理、缺乏合作、结果不可重现以及延长伦理和监管审批流程。此外,还综合了三个机遇主题:不断增长的基础设施和资源、提高的人力和更好的行政流程以及合作倡议。

结论和建议

研究发现,所确定的特征/特点对于阻碍或促进将动物研究转化为人体试验的实践非常重要。研究表明,应该有足够的基础设施和资金、人力资源建设、良好的研究治理、改进的伦理和监管审批流程、多学科合作以及为研究人员提供激励和认可,以克服所确定的挑战,并允许更有效地将动物研究转化为人体试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5d/11411908/ea452dafcd98/12874_2024_2338_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5d/11411908/ea50e50c59a4/12874_2024_2338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5d/11411908/a48909497fda/12874_2024_2338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5d/11411908/ea452dafcd98/12874_2024_2338_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5d/11411908/ea50e50c59a4/12874_2024_2338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5d/11411908/a48909497fda/12874_2024_2338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e5d/11411908/ea452dafcd98/12874_2024_2338_Fig3_HTML.jpg

相似文献

1
Challenges and opportunities of translating animal research into human trials in Ethiopia.埃塞俄比亚将动物研究转化为人体试验的挑战与机遇。
BMC Med Res Methodol. 2024 Sep 19;24(1):211. doi: 10.1186/s12874-024-02338-8.
2
Understanding the investigators: a qualitative study investigating the barriers and enablers to the implementation of local investigator-initiated clinical trials in Ethiopia.了解研究者:一项定性研究,旨在调查在埃塞俄比亚实施本地研究者发起的临床研究的障碍和促进因素。
BMJ Open. 2013 Nov 27;3(11):e003616. doi: 10.1136/bmjopen-2013-003616.
3
Harnessing Clinical Trial Capacity to Mitigate Zoonotic Diseases: The Role of Expert Scientists in Ethiopia.利用临床试验能力减轻人畜共患病:埃塞俄比亚专家科学家的作用。
Front Public Health. 2021 Apr 1;9:621433. doi: 10.3389/fpubh.2021.621433. eCollection 2021.
4
Limited capacity in US pediatric drug trials: qualitative analysis of expert interviews.美国儿科药物试验能力有限:专家访谈的定性分析。
Paediatr Drugs. 2011 Apr 1;13(2):119-24. doi: 10.2165/11584240-000000000-00000.
5
International Clinical Trial Day and clinical trials in Ethiopia and Africa.国际临床试验日以及埃塞俄比亚和非洲的临床试验
Trials. 2014 Dec 19;15:493. doi: 10.1186/1745-6215-15-493.
6
Establishing an infrastructure to optimize the integration of genomics into research: Results from a precision health needs assessment.建立优化基因组学融入研究的基础设施:精准健康需求评估的结果。
Transl Behav Med. 2024 Jun 27;14(7):386-393. doi: 10.1093/tbm/ibae008.
7
Strategies for developing sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon and Sri Lanka.在低收入和中等收入国家发展可持续卫生研究能力的策略:一项前瞻性定性研究,调查埃塞俄比亚、喀麦隆和斯里兰卡当地主导开展临床试验的障碍与促进因素。
BMJ Open. 2017 Oct 13;7(10):e017246. doi: 10.1136/bmjopen-2017-017246.
8
Setting up a pragmatic clinical trial in a low-resource setting: A qualitative assessment of GoLBeT, a trial of podoconiosis management in Northern Ethiopia.在资源匮乏环境下开展实用性临床试验:以埃塞俄比亚北部 Podoconiosis 管理试验 GoLBeT 为例的定性评估。
PLoS Negl Trop Dis. 2021 Jul 28;15(7):e0009582. doi: 10.1371/journal.pntd.0009582. eCollection 2021 Jul.
9
Acceptability and barriers to implementation of N-of-1 tests in Ethiopia - a qualitative study.在埃塞俄比亚开展 N-of-1 试验的可接受性和障碍因素:一项定性研究。
BMC Med Res Methodol. 2019 Oct 15;19(1):192. doi: 10.1186/s12874-019-0832-7.
10
Information sharing across institutions: Practices and barriers during public health emergencies in Ethiopia.信息在机构间的共享:埃塞俄比亚公共卫生突发事件期间的实践和障碍。
Int J Med Inform. 2024 Jun;186:105439. doi: 10.1016/j.ijmedinf.2024.105439. Epub 2024 Mar 30.

引用本文的文献

1
Aqueous Extract of Freshwater Clam Increases Alcohol Metabolism in Rats in a Preclinical Model.淡水蛤水提取物在临床前模型中提高大鼠酒精代谢能力。
Nutrients. 2025 Jun 3;17(11):1915. doi: 10.3390/nu17111915.

本文引用的文献

1
Surviving in the Valley of Death: Opportunities and Challenges in Translating Academic Drug Discoveries.在死亡谷中生存:转化学术药物发现的机遇与挑战
Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:405-421. doi: 10.1146/annurev-pharmtox-010818-021625. Epub 2018 Sep 12.
2
A mixed-methods study to explore opinions of research translation held by researchers working in a Centre of Research Excellence in Australia.一项混合方法研究,旨在探究澳大利亚一个卓越研究中心的研究人员对研究转化的看法。
BMJ Open. 2018 Sep 10;8(9):e022357. doi: 10.1136/bmjopen-2018-022357.
3
Strategies for developing sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon and Sri Lanka.
在低收入和中等收入国家发展可持续卫生研究能力的策略:一项前瞻性定性研究,调查埃塞俄比亚、喀麦隆和斯里兰卡当地主导开展临床试验的障碍与促进因素。
BMJ Open. 2017 Oct 13;7(10):e017246. doi: 10.1136/bmjopen-2017-017246.
4
Panacea or diagnosis? Imaginaries of innovation and the 'MIT model' in three political cultures.灵丹妙药还是诊断?三种政治文化中的创新想象与“麻省理工模式”。
Soc Stud Sci. 2017 Dec;47(6):783-810. doi: 10.1177/0306312717706110. Epub 2017 Jun 1.
5
"You can save time if…"-A qualitative study on internal factors slowing down clinical trials in Sub-Saharan Africa.“如果……你就能节省时间”——关于撒哈拉以南非洲地区减缓临床试验的内部因素的定性研究
PLoS One. 2017 Mar 16;12(3):e0173796. doi: 10.1371/journal.pone.0173796. eCollection 2017.
6
Critical evaluation of challenges and future use of animals in experimentation for biomedical research.对生物医学研究实验中动物使用面临的挑战及未来应用的批判性评估。
Int J Immunopathol Pharmacol. 2016 Dec;29(4):551-561. doi: 10.1177/0394632016671728. Epub 2016 Sep 30.
7
Optimising Translational Research Opportunities: A Systematic Review and Narrative Synthesis of Basic and Clinician Scientists' Perspectives of Factors Which Enable or Hinder Translational Research.优化转化研究机会:对基础科学家和临床医生关于促进或阻碍转化研究因素的观点进行系统评价和叙述性综合分析
PLoS One. 2016 Aug 4;11(8):e0160475. doi: 10.1371/journal.pone.0160475. eCollection 2016.
8
Limitations in Translating Animal Studies to Humans in Cardiovascular Disease.将动物研究转化应用于人类心血管疾病研究的局限性。
J Cardiovasc Transl Res. 2016 Apr;9(2):165-6. doi: 10.1007/s12265-016-9676-2. Epub 2016 Jan 15.
9
The Culture of Translational Science Research: Participants' Stories.转化科学研究的文化:参与者的故事
Int Rev Qual Res. 2013 Spring;6(1):127-142. doi: 10.1525/irqr.2013.6.1.127.
10
Understanding the limits of animal models as predictors of human biology: lessons learned from the sbv IMPROVER Species Translation Challenge.理解动物模型作为人类生物学预测指标的局限性:从sbv IMPROVER物种转化挑战赛中汲取的经验教训。
Bioinformatics. 2015 Feb 15;31(4):471-83. doi: 10.1093/bioinformatics/btu611. Epub 2014 Sep 17.